Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Saccharomyces cerevisiae strain:ABC16-Monster

ABSTRACT: Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor

PROVIDER: PRJNA313356 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3480251_1.fastq.gz	Fastqsanger.gz
	SRR3480251_2.fastq.gz	Fastqsanger.gz
	SRR3480212_1.fastq.gz	Fastqsanger.gz
	SRR3480212_2.fastq.gz	Fastqsanger.gz
	SRR3480136_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

Project description:Chemical Genomics Profiling of Antimalarial Drugs

| PRJNA689872 | ENA

Saccharomyces cerevisiae

Project description:Chemical genomics study of Snf1 as a gene repressor

| PRJNA113395 | ENA

Genome-wide binding of THO and Sub2 in Saccharomyces cerevisiae

Project description:THO/TREX is a conserved nuclear complex that functions in mRNP biogenesis and prevents transcription-associated recombination. Whether or not it has a ubiquitous role in the genome is an open question. ChIP-chip studies reveal that the Hpr1 component of THO and the Sub2 RNA-dependent ATPase have genome wide-distributions at active ORFs in yeast. In contrast to RNAPII, evenly distributed from promoter to termination regions, THO and Sub2 are absent at promoters and distributed in a sharp 5M-bM-^@M-^YM-bM-^FM-^R3M-bM-^@M-^Y gradient. Importantly, ChIP-chips reveal an over-recruitment of Rrm3 in active genes in THO mutants that is reduced by overexpression of RNase H1. Our work establishes a genome-wide function for THO-Sub2 in transcription elongation and mRNP biogenesis that function to prevent the accumulation of transcription-mediated replication obstacles, including R-loops. ChIP-chip studies were perfomed with tagged forms of the Hpr1 component of THO (Hpr1-FLAG), the Sub2 RNA-dependent ATPase of TREX (Sub2-FLAG), the Rpb3 subunit of RNA polymerase II (Rpb3-PK) and the Rrm3 protein (Rrm3-FLAG) in the yeast S. cerevisiae.

2011-06-28 | E-GEOD-24960 | biostudies-arrayexpress

Saccharomyces cerevisiae

Project description:Comparative genomics of Saccharomyces cerevisiae strains using PacBio long-read sequencing

| PRJNA349093 | ENA

Genome-wide expression profiling of the cryptolepine-induced toxicity in Saccharomyces cerevisiae

Project description:We have used the budding yeast Saccharomyces cerevisiae to identify genes that may confer sensitivity in vivo to the antimalarial and cytotoxic agent cryptolepine. To this end, five S. cerevisiae strains, which differ in the condition of genes related to cell membrane integrity and to DNA damage repair, were exposed to several concentrations of cryptolepine. Results showed a relatively mild toxicity of cryptolepine for wild type strains, which increased by either increasing cell permeability (∆erg6 or ISE2 strains) or disrupting DNA damage repair (∆rad52 strains). These results are compatible with the ability of cryptolepine to intercalate into DNA and therefore, promote DNA lesions. The effects of low concentrations of cryptolepine (IC20 and IC40) were then analysed by comparison between gene expression profiles of treated and untreated ∆erg6 yeast cells. Significant changes in expression levels were observed for 349 genes (117 up-regulated and 232 down-regulated). General stress-related genes constituted the only recognizable functional cluster whose expression was increased upon cryptolepine treatment, making up about 20% of up-regulated genes. In contrast, analysis of characteristics of down-regulated genes revealed a specific effect of cryptolepine on genes related to iron-transport or acid phosphatases, as well as a significant proportion of cell wall components. In particular, the effects of cryptolepine treatment on transcription of iron transport-related genes were compatible with of a loss-of-function of the iron sensor Aft1p, indicating a possible disruption of the iron metabolism is S. cerevisiae. As iron metabolism is one of the putative antimalarial effects of cryptolepine, this finding exemplarises the utility of S. cerevisiae in drug-developing schemes. These results are analyzed in the context of the known cryptolepine activities as antimalarial and cytotoxic drug.

2008-08-08 | GSE12192 | GEO

Saccharomyces cerevisiae

Project description:Comparative genomics reveals Chd1 as a determinant of nucleosome spacing in vivo

| PRJNA278642 | ENA

Saccharomyces cerevisiae

Project description:Cohesin releases DNA through asymmetric ATPase-driven ring opening

| PRJNA308861 | ENA

Saccharomyces cerevisiae

Project description:Expression data from early response of Saccharomyces cerevisiae to the antimalarial drug quinine

| PRJNA119893 | ENA

Saccharomyces cerevisiae

Project description:Comparative transcriptomes reveal novel evolutionary strategies adopted by Saccharomyces cerevisiae with improved xylose utilization capability

| PRJNA320085 | ENA

Saccharomyces cerevisiae

Project description:Comparative transcriptome analysis of Saccharomyces cerevisiae wild type and Δasc1 strain

| PRJNA149949 | ENA